Accutar Biotech

Accutar Biotech, founded in 2016, is a targeted therapy service provider dedicated to improving the accuracy and efficiency of drug screening through AI technology, building an algorithm platform to accelerate the development of a new generation of drugs. Accutar Biotech has already utilized artificial intelligence methods for drug design based on protein crystallography data and has applied for two patents in the United States. Accutar Biotech is an AI-powered biopharmaceutical platform that relies on computational design and experimental validation for the treatment of certain specific diseases, accelerating the development of therapeutic drugs.